Construction of a viral T2A-peptide based knock-in mouse model for enhanced Cre recombinase activity and fluorescent

Sybille Koehler1, Sebastian Brähler2, Fabian Braun1

  • 1Department II of Internal Medicine and Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany.

Kidney International
|February 12, 2017
PubMed

Insights

Researchers developed a new mouse model for studying kidney podocyte health. This tricistronic model offers improved gene editing efficiency and fluorescent labeling for better podocyte research and disease modeling.

Area of Science:

  • Nephrology
  • Genetics
  • Molecular Biology

Background:

  • Podocyte injury is central to glomerular diseases, driving proteinuria and kidney scarring.
  • Understanding podocyte molecular mechanisms is crucial for therapeutic development.
  • Existing mouse models like hNphs2.Cre facilitate podocyte gene manipulation but have limitations.

Purpose of the Study:

  • To create an improved podocyte-specific mouse model for genetic manipulation and lineage tracing.
  • To combine enhanced Cre recombinase activity with fluorescent labeling in a single, efficient tool.
  • To validate the model's safety, efficacy, and utility in disease contexts.

Main Methods:

  • Designed a novel tricistronic mouse model (Nphs2pod.T2A.ciCre.T2A.mTomato/wild-type) using the Nphs2 promoter and viral T2A-peptides.
  • Confirmed independent expression of podocin, Cre, and mTomato via immunofluorescence and flow cytometry.
  • Assessed Cre recombination efficiency and disease phenotype in comparison to conventional hNphs2.Cre mice using Phb2 knockout models.

Main Results:

  • The novel tricistronic model demonstrated normal development without glomerular pathology or off-target effects.
  • Achieved superior gene recombination efficiency compared to conventional hNphs2.Cre mice.
  • Podocyte-specific Phb2 knockout using the new model exacerbated glomerular injury more than with the hNphs2.Cre model.

Conclusions:

  • The Nphs2pod.T2A.ciCre.T2A.mTomato/wild-type mouse is the first tricistronic model for enhanced podocyte-specific gene editing and fluorescent labeling.
  • This model offers improved Cre efficiency and simplifies research by eliminating the need for separate reporter lines.
  • It provides a powerful new tool for investigating podocyte function and glomerular disease pathogenesis.